These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 7513124)
1. Activation of PI 3-kinase in 3T3-L1 adipocytes by association with insulin receptor substrate-1. Lamphere L; Carpenter CL; Sheng ZF; Kallen RG; Lienhard GE Am J Physiol; 1994 Mar; 266(3 Pt 1):E486-94. PubMed ID: 7513124 [TBL] [Abstract][Full Text] [Related]
2. Regulation of insulin receptor, insulin receptor substrate-1 and phosphatidylinositol 3-kinase in 3T3-F442A adipocytes. Effects of differentiation, insulin, and dexamethasone. Saad MJ; Folli F; Araki E; Hashimoto N; Csermely P; Kahn CR Mol Endocrinol; 1994 May; 8(5):545-57. PubMed ID: 7520127 [TBL] [Abstract][Full Text] [Related]
3. Potent activation of phosphatidylinositol 3'-kinase by simple phosphotyrosine peptides derived from insulin receptor substrate 1 containing two YMXM motifs for binding SH2 domains. Herbst JJ; Andrews G; Contillo L; Lamphere L; Gardner J; Lienhard GE; Gibbs EM Biochemistry; 1994 Aug; 33(32):9376-81. PubMed ID: 7520748 [TBL] [Abstract][Full Text] [Related]
4. Modulation of insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of dexamethasone-treated rats. Saad MJ; Folli F; Kahn JA; Kahn CR J Clin Invest; 1993 Oct; 92(4):2065-72. PubMed ID: 7691892 [TBL] [Abstract][Full Text] [Related]
5. Growth hormone induces cellular insulin resistance by uncoupling phosphatidylinositol 3-kinase and its downstream signals in 3T3-L1 adipocytes. Takano A; Haruta T; Iwata M; Usui I; Uno T; Kawahara J; Ueno E; Sasaoka T; Kobayashi M Diabetes; 2001 Aug; 50(8):1891-900. PubMed ID: 11473053 [TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor promotes phosphorylation and binding of insulin receptor substrate 1 to phosphatidylinositol 3-kinase in 3T3-L1 adipocytes. Guo D; Donner DB J Biol Chem; 1996 Jan; 271(2):615-8. PubMed ID: 8557661 [TBL] [Abstract][Full Text] [Related]
7. Persistent activation of phosphatidylinositol 3-kinase causes insulin resistance due to accelerated insulin-induced insulin receptor substrate-1 degradation in 3T3-L1 adipocytes. Egawa K; Nakashima N; Sharma PM; Maegawa H; Nagai Y; Kashiwagi A; Kikkawa R; Olefsky JM Endocrinology; 2000 Jun; 141(6):1930-5. PubMed ID: 10830273 [TBL] [Abstract][Full Text] [Related]
9. Reciprocal feedback regulation of insulin receptor and insulin receptor substrate tyrosine phosphorylation by phosphoinositide 3-kinase in primary adipocytes. Hers I; Bell CJ; Poole AW; Jiang D; Denton RM; Schaefer E; Tavaré JM Biochem J; 2002 Dec; 368(Pt 3):875-84. PubMed ID: 12220227 [TBL] [Abstract][Full Text] [Related]
10. Growth hormone stimulates the tyrosine phosphorylation of the insulin receptor substrate-1 and its association with phosphatidylinositol 3-kinase in primary adipocytes. Ridderstråle M; Degerman E; Tornqvist H J Biol Chem; 1995 Feb; 270(8):3471-4. PubMed ID: 7876077 [TBL] [Abstract][Full Text] [Related]
11. Angiotensin II induces tyrosine phosphorylation of insulin receptor substrate 1 and its association with phosphatidylinositol 3-kinase in rat heart. Saad MJ; Velloso LA; Carvalho CR Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):741-4. PubMed ID: 7575404 [TBL] [Abstract][Full Text] [Related]
12. Pioglitazone promotes insulin-induced activation of phosphoinositide 3-kinase in 3T3-L1 adipocytes by inhibiting a negative control mechanism. Sizer KM; Smith CL; Jacob CS; Swanson ML; Bleasdale JE Mol Cell Endocrinol; 1994 Jul; 103(1-2):1-12. PubMed ID: 7525381 [TBL] [Abstract][Full Text] [Related]
13. Cross-talk between the platelet-derived growth factor and the insulin signaling pathways in 3T3-L1 adipocytes. Ricort JM; Tanti JF; Van Obberghen E; Le Marchand-Brustel Y J Biol Chem; 1997 Aug; 272(32):19814-8. PubMed ID: 9242642 [TBL] [Abstract][Full Text] [Related]
14. Subcellular localization of insulin receptor substrate family proteins associated with phosphatidylinositol 3-kinase activity and alterations in lipolysis in primary mouse adipocytes from IRS-1 null mice. Tsuji Y; Kaburagi Y; Terauchi Y; Satoh S; Kubota N; Tamemoto H; Kraemer FB; Sekihara H; Aizawa S; Akanuma Y; Tobe K; Kimura S; Kadowaki T Diabetes; 2001 Jun; 50(6):1455-63. PubMed ID: 11375348 [TBL] [Abstract][Full Text] [Related]
15. Serine/threonine phosphorylation of insulin receptor substrate 1 modulates insulin receptor signaling. Tanti JF; Grémeaux T; van Obberghen E; Le Marchand-Brustel Y J Biol Chem; 1994 Feb; 269(8):6051-7. PubMed ID: 8119950 [TBL] [Abstract][Full Text] [Related]
16. Effect of glucagon on insulin receptor substrate-1 (IRS-1) phosphorylation and association with phosphatidylinositol 3-kinase (PI 3-kinase). Saad MJ; Hartmann LG; de Carvalho DS; Galoro CA; Brenelli SL; Carvalho CR FEBS Lett; 1995 Aug; 370(1-2):131-4. PubMed ID: 7544300 [TBL] [Abstract][Full Text] [Related]
17. Regulation of phosphatidylinositol 3-kinase activity in liver and muscle of animal models of insulin-resistant and insulin-deficient diabetes mellitus. Folli F; Saad MJ; Backer JM; Kahn CR J Clin Invest; 1993 Oct; 92(4):1787-94. PubMed ID: 7691886 [TBL] [Abstract][Full Text] [Related]
18. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity. Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900 [TBL] [Abstract][Full Text] [Related]
19. Insulin-stimulated phosphatidylinositol 3-kinase. Association with a 185-kDa tyrosine-phosphorylated protein (IRS-1) and localization in a low density membrane vesicle. Kelly KL; Ruderman NB J Biol Chem; 1993 Feb; 268(6):4391-8. PubMed ID: 8382701 [TBL] [Abstract][Full Text] [Related]
20. Effect of aging on insulin receptor, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in liver and muscle of rats. Carvalho CR; Brenelli SL; Silva AC; Nunes AL; Velloso LA; Saad MJ Endocrinology; 1996 Jan; 137(1):151-9. PubMed ID: 8536607 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]